|
Market Closed -
Bombay S.E.
14:23:40 11/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 115.95 INR | +0.69% |
|
+1.98% | +182.32% |
| 08-05 | Morepen Laboratories Limited announces Annual dividend, payable on October 26, 2026 | CI |
| 08-04 | Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 63.54B 665M 573M 543M 492M 923M 927M 6.44B 2.48B 32.32B 2.5B 2.44B 102B | P/E 2025 |
21.8x | P/E 2026 | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 65.07B 681M 587M 556M 504M 945M 950M 6.6B 2.54B 33.11B 2.56B 2.5B 105B | EV / Sales 2025 |
1.45x | EV / Sales 2026 | 1.11x |
| Free-Float |
57.31% | Yield 2025 |
0.42% | Yield 2026 | 0.59% |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| MOREPENLAB | Delayed | |
NSE India S.E.
| MOREPENLAB | Delayed |
| 1 day | +0.69% | ||
| 1 week | +1.98% | ||
| Current month | +8.25% | ||
| 1 month | +50.80% | ||
| 3 months | +145.29% | ||
| 6 months | +189.15% | ||
| Current year | +182.32% |
| 1 week | 111.25 |  | 122.45 |
| 1 month | 73.56 | | 122.45 |
| Current year | 33.44 | | 122.45 |
| 1 year | 33.44 | | 122.45 |
| 3 years | 31.31 | | 122.45 |
| 5 years | 23.65 | | 122.45 |
| 10 years | 7.21 | | 122.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 58 | 01/07/2026 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 01/02/1992 |
| Director of Finance/CFO | 59 | 03/04/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 01/02/1992 |
| Director/Board Member | 58 | 13/08/2019 | |
Savita
BRD | Director/Board Member | - | 22/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.69% | +1.98% | +114.21% | +198.53% | 665M | |
| -0.65% | -2.93% | +47.52% | +87.34% | 994B | |
| -0.29% | -3.51% | +48.78% | +63.27% | 640B | |
| +0.83% | +0.26% | +16.76% | +72.52% | 454B | |
| -0.38% | -3.59% | +28.24% | +35.57% | 337B | |
| -0.09% | -13.54% | +10.08% | +26.87% | 261B | |
| -0.43% | -2.48% | -2.07% | +11.48% | 246B | |
| -1.34% | -13.70% | +33.47% | +44.18% | 204B | |
| -3.44% | -7.51% | -20.08% | -59.58% | 190B | |
| -0.75% | -4.82% | +21.94% | +86.55% | 178B | |
| Average | -0.59% | -4.98% | +29.88% | +56.67% | 350.54B | |
| Weighted average by Cap. | -0.51% | -4.41% | +29.88% | +55.74% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 18.12B 190M 163M 155M 140M 263M 264M 1.84B 707M 9.22B 712M 697M 29.12B | 18.06B 189M 163M 154M 140M 262M 264M 1.83B 704M 9.19B 710M 694M 29.03B |
| Net income | 1.18B 12.35M 10.64M 10.08M 9.13M 17.14M 17.22M 120M 46.03M 600M 46.4M 45.38M 1.9B | 949M 9.93M 8.56M 8.1M 7.34M 13.78M 13.85M 96.23M 37M 483M 37.3M 36.48M 1.53B |
| Net Debt | -928K -9.71K -8.37K -7.92K -7.18K -13.48K -13.54K -94.12K -36.19K -472K -36.48K -35.68K -1.49M | 1.54B 16.1M 13.87M 13.13M 11.9M 22.33M 22.45M 156M 59.98M 782M 60.46M 59.13M 2.47B |
Employees
1,919
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | ₹115.95 | +0.69% | 972,729 |
| 10/09/26 | ₹115.15 | -1.20% | 847,362 |
| 09/09/26 | ₹116.55 | -0.34% | 816,939 |
| 08/09/26 | ₹116.95 | -1.43% | 1,171,670 |
| 07/09/26 | ₹118.65 | +4.35% | 1,401,707 |
- Stock Market
- Stocks
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
